Pembrolizumab - CAS 1374853-91-4

Pembrolizumab (MK-3475) is a highly selective humanized monoclonal antibody that antagonizes PD-1. It can block the PD-1 protein on T cells and prevent their interaction with PD-L1 on cancer cells.

PD-1/PD-L1

Apoptosis, Immunology/Inflammation, Cell Cycle/Checkpoint

1374758

0.997

-20°C

Ice Packs

Inhibitory Antibodies